UniProt ID | OXSR1_HUMAN | |
---|---|---|
UniProt AC | O95747 | |
Protein Name | Serine/threonine-protein kinase OSR1 | |
Gene Name | OXSR1 {ECO:0000312|HGNC:HGNC:8508} | |
Organism | Homo sapiens (Human). | |
Sequence Length | 527 | |
Subcellular Localization | Cytoplasm . | |
Protein Description | Regulates downstream kinases in response to environmental stress. May also have a function in regulating the actin cytoskeleton.. | |
Protein Sequence | MSEDSSALPWSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAKNKEFLQEKTLQRAPTISERAKKVRRVPGSSGRLHKTEDGGWEWSDDEFDEESEEGKAAISQLRSPRVKESISNSELFPTTDPVGTLLQVPEQISAHLPQPAGQIATQPTQVSLPPTAEPAKTAQALSSGSGSQETKIPISLVLRLRNSKKELNDIRFEFTPGRDTAEGVSQELISAGLVDGRDLVIVAANLQKIVEEPQSNRSVTFKLASGVEGSDIPDDGKLIGFAQLSIS | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Phosphorylation | ------MSEDSSALP ------CCCCCCCCC | 50.54 | 20873877 | |
2 | Acetylation | ------MSEDSSALP ------CCCCCCCCC | 50.54 | 22223895 | |
5 | Phosphorylation | ---MSEDSSALPWSI ---CCCCCCCCCCCC | 17.29 | 20873877 | |
6 | Phosphorylation | --MSEDSSALPWSIN --CCCCCCCCCCCCC | 46.26 | 20873877 | |
42 | Acetylation | YCAPKKEKVAIKRIN HHCCCCCCEEEEECC | 45.93 | 88637 | |
46 | Acetylation | KKEKVAIKRINLEKC CCCCEEEEECCHHHH | 37.17 | 88635 | |
52 | Ubiquitination | IKRINLEKCQTSMDE EEECCHHHHCCCHHH | 34.51 | 30230243 | |
55 | Phosphorylation | INLEKCQTSMDELLK CCHHHHCCCHHHHHH | 35.17 | 23917254 | |
56 | Phosphorylation | NLEKCQTSMDELLKE CHHHHCCCHHHHHHH | 9.81 | 23917254 | |
81 | Ubiquitination | NIVSYYTSFVVKDEL CHHHHEEEEEECHHH | 10.42 | 22817900 | |
105 | Ubiquitination | GSVLDIIKHIVAKGE CCHHHHHHHHHHCCC | 27.84 | 29967540 | |
110 | Ubiquitination | IIKHIVAKGEHKSGV HHHHHHHCCCCCCCC | 54.67 | 29967540 | |
114 | Ubiquitination | IVAKGEHKSGVLDES HHHCCCCCCCCCCHH | 44.60 | 29967540 | |
139 | Acetylation | EGLEYLHKNGQIHRD HHHHHHHHCCCCCCC | 61.24 | 25953088 | |
139 | Ubiquitination | EGLEYLHKNGQIHRD HHHHHHHHCCCCCCC | 61.24 | 29967540 | |
148 | Ubiquitination | GQIHRDVKAGNILLG CCCCCCCCCCCEEEC | 55.66 | 22817900 | |
178 | Phosphorylation | LATGGDITRNKVRKT EEECCCCCCCCCCCC | 32.69 | - | |
184 | Ubiquitination | ITRNKVRKTFVGTPC CCCCCCCCCCCCCCC | 49.67 | 30230243 | |
185 | Phosphorylation | TRNKVRKTFVGTPCW CCCCCCCCCCCCCCC | 17.00 | 22322096 | |
189 | Phosphorylation | VRKTFVGTPCWMAPE CCCCCCCCCCCCCHH | 15.24 | 23403867 | |
201 | Ubiquitination | APEVMEQVRGYDFKA CHHHHHHHCCCCCCH | 3.06 | 22817900 | |
227 | Phosphorylation | LATGAAPYHKYPPMK HHHCCCCCCCCCCCE | 13.25 | 20044836 | |
230 | Phosphorylation | GAAPYHKYPPMKVLM CCCCCCCCCCCEEEE | 10.15 | 20044836 | |
253 | Ubiquitination | SLETGVQDKEMLKKY CCCCCCCCHHHHHHH | 46.61 | 24816145 | |
254 | Ubiquitination | LETGVQDKEMLKKYG CCCCCCCHHHHHHHH | 28.12 | 29967540 | |
260 | Phosphorylation | DKEMLKKYGKSFRKM CHHHHHHHHHHHHHH | 28.35 | 26074081 | |
263 | Phosphorylation | MLKKYGKSFRKMISL HHHHHHHHHHHHHHH | 26.39 | 26074081 | |
266 | Malonylation | KYGKSFRKMISLCLQ HHHHHHHHHHHHHHC | 38.28 | 26320211 | |
269 | Phosphorylation | KSFRKMISLCLQKDP HHHHHHHHHHHCCCH | 14.99 | 26074081 | |
278 | Acetylation | CLQKDPEKRPTAAEL HHCCCHHHCCCHHHH | 69.90 | 25953088 | |
278 | Ubiquitination | CLQKDPEKRPTAAEL HHCCCHHHCCCHHHH | 69.90 | 29967540 | |
287 | Methylation | PTAAELLRHKFFQKA CCHHHHHHHHHHHHH | 43.50 | 115486091 | |
289 | Acetylation | AAELLRHKFFQKAKN HHHHHHHHHHHHHCC | 41.25 | 26051181 | |
297 | Methylation | FFQKAKNKEFLQEKT HHHHHCCHHHHHHHH | 49.49 | 115974491 | |
303 | Ubiquitination | NKEFLQEKTLQRAPT CHHHHHHHHHHCCCC | 41.39 | 32015554 | |
304 | Phosphorylation | KEFLQEKTLQRAPTI HHHHHHHHHHCCCCH | 27.63 | 23882029 | |
310 | Phosphorylation | KTLQRAPTISERAKK HHHHCCCCHHHHHHH | 35.83 | 23911959 | |
312 | Phosphorylation | LQRAPTISERAKKVR HHCCCCHHHHHHHHH | 24.41 | 29514088 | |
324 | Phosphorylation | KVRRVPGSSGRLHKT HHHCCCCCCCCCEEC | 24.45 | 25159151 | |
325 | Phosphorylation | VRRVPGSSGRLHKTE HHCCCCCCCCCEECC | 33.57 | 25159151 | |
331 | Phosphorylation | SSGRLHKTEDGGWEW CCCCCEECCCCCCCC | 28.67 | 22167270 | |
339 | Phosphorylation | EDGGWEWSDDEFDEE CCCCCCCCCCCCCCC | 24.54 | 19664994 | |
347 | Phosphorylation | DDEFDEESEEGKAAI CCCCCCCCHHHHHHH | 38.61 | 22167270 | |
355 | Phosphorylation | EEGKAAISQLRSPRV HHHHHHHHHHCCHHH | 20.59 | 25159151 | |
359 | Phosphorylation | AAISQLRSPRVKESI HHHHHHCCHHHHHCC | 26.17 | 29255136 | |
365 | Phosphorylation | RSPRVKESISNSELF CCHHHHHCCCCCCCC | 26.12 | 21406692 | |
367 | Phosphorylation | PRVKESISNSELFPT HHHHHCCCCCCCCCC | 43.51 | 21406692 | |
369 | Phosphorylation | VKESISNSELFPTTD HHHCCCCCCCCCCCC | 28.96 | 29496963 | |
374 | Phosphorylation | SNSELFPTTDPVGTL CCCCCCCCCCCCCCH | 36.17 | 21406692 | |
375 | Phosphorylation | NSELFPTTDPVGTLL CCCCCCCCCCCCCHH | 38.25 | 21406692 | |
378 | Ubiquitination | LFPTTDPVGTLLQVP CCCCCCCCCCHHCCC | 11.57 | 24816145 | |
417 | Phosphorylation | PTAEPAKTAQALSSG CCCCCCHHHHHHHCC | 26.55 | 23403867 | |
417 | O-linked_Glycosylation | PTAEPAKTAQALSSG CCCCCCHHHHHHHCC | 26.55 | OGP | |
422 | Phosphorylation | AKTAQALSSGSGSQE CHHHHHHHCCCCCCC | 35.35 | 28176443 | |
423 | Phosphorylation | KTAQALSSGSGSQET HHHHHHHCCCCCCCC | 37.52 | 28176443 | |
425 | Phosphorylation | AQALSSGSGSQETKI HHHHHCCCCCCCCCC | 36.90 | 25159151 | |
427 | Phosphorylation | ALSSGSGSQETKIPI HHHCCCCCCCCCCCH | 26.92 | 25159151 | |
430 | Phosphorylation | SGSGSQETKIPISLV CCCCCCCCCCCHHHE | 27.00 | 25159151 | |
435 | Phosphorylation | QETKIPISLVLRLRN CCCCCCHHHEEHHCC | 13.68 | 30108239 | |
443 | Phosphorylation | LVLRLRNSKKELNDI HEEHHCCCCCHHCCC | 38.38 | 24719451 | |
444 | Methylation | VLRLRNSKKELNDIR EEHHCCCCCHHCCCE | 54.54 | 116251977 | |
445 | Ubiquitination | LRLRNSKKELNDIRF EHHCCCCCHHCCCEE | 68.22 | 24816145 | |
451 | Methylation | KKELNDIRFEFTPGR CCHHCCCEEEECCCC | 28.10 | - | |
486 | Ubiquitination | LVIVAANLQKIVEEP EEEEEECHHHHHCCC | 4.74 | 24816145 | |
495 | O-linked_Glycosylation | KIVEEPQSNRSVTFK HHHCCCCCCCCEEEE | 44.95 | 30620550 | |
498 | Ubiquitination | EEPQSNRSVTFKLAS CCCCCCCCEEEEECC | 29.74 | 24816145 | |
510 | Phosphorylation | LASGVEGSDIPDDGK ECCCCCCCCCCCCCC | 20.89 | 25159151 |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of OXSR1_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of OXSR1_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
TGFR1_HUMAN | TGFBR1 | physical | 15761153 | |
TGFR2_HUMAN | TGFBR2 | physical | 15761153 | |
A4_HUMAN | APP | physical | 21832049 | |
RNH2C_HUMAN | RNASEH2C | physical | 22939629 | |
SLFN5_HUMAN | SLFN5 | physical | 22939629 | |
AN32A_HUMAN | ANP32A | physical | 22863883 | |
RL17_HUMAN | RPL17 | physical | 22863883 | |
UBP5_HUMAN | USP5 | physical | 22863883 | |
AIFM1_HUMAN | AIFM1 | physical | 23455922 | |
MD2L1_HUMAN | MAD2L1 | physical | 23455922 | |
RELL2_HUMAN | RELL2 | physical | 25416956 | |
THUM1_HUMAN | THUMPD1 | physical | 26344197 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-339 AND SER-347, ANDMASS SPECTROMETRY. | |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-339 AND SER-427, ANDMASS SPECTROMETRY. | |
"Large-scale phosphoproteome analysis of human liver tissue byenrichment and fractionation of phosphopeptides with strong anionexchange chromatography."; Han G., Ye M., Zhou H., Jiang X., Feng S., Jiang X., Tian R., Wan D.,Zou H., Gu J.; Proteomics 8:1346-1361(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-339, AND MASSSPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-339 AND SER-427, ANDMASS SPECTROMETRY. | |
"ATM and ATR substrate analysis reveals extensive protein networksresponsive to DNA damage."; Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.; Science 316:1160-1166(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-427, AND MASSSPECTROMETRY. | |
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-339, AND MASSSPECTROMETRY. |